7Baggers
Quarterly
Annual
    Unit: USD2025-08-28 2025-05-29 2025-02-27 2024-11-28 2024-08-29 2024-05-30 2024-02-29 2023-11-30 2023-08-31 2023-06-01 2023-03-02 2022-12-01 2022-09-01 2022-06-02 2022-03-03 2021-12-02 2021-09-02 2021-06-03 2021-03-04 2020-12-03 2020-09-03 2020-05-28 2020-02-27 2019-11-28 2019-08-29 2019-05-30 2019-02-28 2018-11-29 2018-08-30 2018-05-31 2018-03-01 2017-11-30 2014-08-28 2014-05-29 2014-02-27 2013-11-28 
      
    		                                    
      cash flows from operating activities
    		                                    
      net income
    		3,201,000,000 1,885,000,000 1,583,000,000 1,870,000,000 887,000,000 332,000,000 793,000,000 -1,234,000,000 -1,430,000,000 -1,896,000,000 -2,312,000,000 -195,000,000 1,492,000,000 2,626,000,000 2,263,000,000 2,306,000,000 2,720,000,000 1,735,000,000 603,000,000 803,000,000 990,000,000 805,000,000 407,000,000 508,000,000 586,000,000 851,000,000 1,625,000,000 3,296,000,000 4,326,000,000 3,823,000,000 3,311,000,000 2,678,000,000 1,151,000,000 806,000,000 741,000,000 381,000,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                    
      depreciation expense and amortization of intangible assets
    		2,149,000,000 2,094,000,000 2,079,000,000 2,030,000,000 1,986,000,000 1,955,000,000 1,924,000,000 1,915,000,000 1,937,000,000 1,956,000,000 1,942,000,000 1,921,000,000 1,882,000,000 1,821,000,000 1,742,000,000 1,671,000,000 1,621,000,000 1,557,000,000 1,549,000,000 1,487,000,000 1,567,000,000 1,422,000,000 1,365,000,000 1,296,000,000 1,416,000,000 1,360,000,000 1,313,000,000 1,335,000,000 1,285,000,000 1,233,000,000 1,151,000,000 1,090,000,000 553,000,000 542,000,000 517,000,000 491,000,000 
      stock-based compensation
    		250,000,000 253,000,000 249,000,000 220,000,000 213,000,000 219,000,000 213,000,000 188,000,000 148,000,000 145,000,000 157,000,000 146,000,000 136,000,000 131,000,000 129,000,000 118,000,000 93,000,000 96,000,000 97,000,000 92,000,000 89,000,000 82,000,000 85,000,000 72,000,000 67,000,000 58,000,000 57,000,000 61,000,000 47,000,000 48,000,000 52,000,000 51,000,000 34,000,000 32,000,000 27,000,000 22,000,000 
      provision to write down inventories to net realizable value
    		        0                            
      goodwill impairment
    		                                    
      change in operating assets and liabilities:
    		                                    
      receivables
    		-1,653,000,000 -461,000,000 1,155,000,000 -817,000,000 -1,019,000,000 -803,000,000 -1,258,000,000 -501,000,000 35,000,000 -182,000,000 1,068,000,000 1,842,000,000 1,096,000,000 -862,000,000 -111,000,000 67,000,000 -1,106,000,000 -873,000,000 282,000,000 251,000,000 -262,000,000 -565,000,000 312,000,000 -208,000,000 58,000,000 1,171,000,000 1,013,000,000 189,000,000 -557,000,000 -547,000,000 -509,000,000 -121,000,000 -188,000,000 128,000,000 36,000,000 -494,000,000 
      inventories
    		372,000,000 280,000,000 -302,000,000 170,000,000 -363,000,000 -68,000,000 -168,000,000 111,000,000 -149,000,000 -510,000,000 -1,199,000,000 -1,697,000,000 -1,033,000,000 -246,000,000 -556,000,000 -344,000,000 52,000,000 185,000,000 543,000,000 86,000,000 -203,000,000 -196,000,000 -265,000,000 175,000,000 -213,000,000 -515,000,000 -514,000,000 -286,000,000 -226,000,000 -184,000,000 -25,000,000 -37,000,000 77,000,000 -71,000,000 -2,000,000 190,000,000 
      accounts payable and accrued expenses
    		824,000,000 752,000,000 -473,000,000 -241,000,000 1,069,000,000 273,000,000 302,000,000 271,000,000 -340,000,000 31,000,000 -739,000,000 -1,056,000,000 362,000,000 275,000,000 149,000,000 -42,000,000 519,000,000 468,000,000 -24,000,000 -753,000,000 25,000,000 443,000,000 79,000,000 178,000,000 529,000,000 -377,000,000 -280,000,000 -46,000,000 511,000,000 -55,000,000 354,000,000 -261,000,000 96,000,000 86,000,000 81,000,000 408,000,000 
      other current liabilities
    		409,000,000 -360,000,000 -160,000,000 -161,000,000 220,000,000 63,000,000 127,000,000 579,000,000                             
      other
    		-28,000,000 168,000,000 15,000,000 173,000,000 -23,000,000 147,000,000 85,000,000 72,000,000 -64,000,000 79,000,000 -4,000,000 -18,000,000 -159,000,000 50,000,000 66,000,000 25,000,000 -75,000,000 21,000,000 -14,000,000 18,000,000 6,000,000 38,000,000 -7,000,000 3,000,000 -185,000,000 -39,000,000 -1,000,000 65,000,000 -204,000,000 -65,000,000 -2,000,000 12,000,000 -155,000,000 59,000,000 -57,000,000 182,000,000 
      net cash from operating activities
    		5,730,000,000 4,609,000,000 3,942,000,000 3,244,000,000 3,405,000,000 2,482,000,000 1,219,000,000 1,401,000,000 249,000,000 24,000,000 343,000,000 943,000,000 3,777,000,000 3,838,000,000 3,628,000,000 3,938,000,000 3,884,000,000 3,560,000,000 3,057,000,000 1,967,000,000 2,271,000,000 2,023,000,000 2,001,000,000 2,011,000,000 2,233,000,000 2,711,000,000 3,435,000,000 4,810,000,000 5,155,000,000 4,261,000,000 4,348,000,000 3,636,000,000 1,347,000,000 1,455,000,000 1,390,000,000 1,507,000,000 
      capex
    		-5,658,000,000 -2,938,000,000 -4,055,000,000 -3,206,000,000 -3,120,000,000 -2,086,000,000 -1,384,000,000 -1,796,000,000 -1,461,000,000 -1,561,000,000 -2,205,000,000 -2,449,000,000 -3,613,000,000 -2,578,000,000 -2,611,000,000 -3,265,000,000 -2,015,000,000 -2,259,000,000 -3,018,000,000 -2,738,000,000 -2,280,000,000 -1,944,000,000 -2,056,000,000 -1,943,000,000 -2,028,000,000 -2,403,000,000 -2,649,000,000 -2,700,000,000 -2,251,000,000 -2,411,000,000 -2,261,000,000 -1,956,000,000 -1,140,000,000 -487,000,000 -505,000,000 -526,000,000 
      free cash flows
    		72,000,000 1,671,000,000 -113,000,000 38,000,000 285,000,000 396,000,000 -165,000,000 -395,000,000 -1,212,000,000 -1,537,000,000 -1,862,000,000 -1,506,000,000 164,000,000 1,260,000,000 1,017,000,000 673,000,000 1,869,000,000 1,301,000,000 39,000,000 -771,000,000 -9,000,000 79,000,000 -55,000,000 68,000,000 205,000,000 308,000,000 786,000,000 2,110,000,000 2,904,000,000 1,850,000,000 2,087,000,000 1,680,000,000 207,000,000 968,000,000 885,000,000 981,000,000 
      cash flows from investing activities
    		                                    
      expenditures for property, plant, and equipment
    		-5,658,000,000 -2,938,000,000 -4,055,000,000 -3,206,000,000 -3,120,000,000 -2,086,000,000 -1,384,000,000 -1,796,000,000 -1,461,000,000 -1,561,000,000 -2,205,000,000 -2,449,000,000 -3,613,000,000 -2,578,000,000 -2,611,000,000 -3,265,000,000 -2,015,000,000 -2,259,000,000 -3,018,000,000 -2,738,000,000 -2,280,000,000 -1,944,000,000 -2,056,000,000 -1,943,000,000 -2,028,000,000 -2,403,000,000 -2,649,000,000 -2,700,000,000 -2,251,000,000 -2,411,000,000 -2,261,000,000 -1,956,000,000     
      purchases of available-for-sale securities
    		-687,000,000 -387,000,000 -439,000,000 -377,000,000 -889,000,000 -645,000,000 -266,000,000 -199,000,000 -227,000,000 -203,000,000 -203,000,000 -90,000,000 -411,000,000 -437,000,000 -394,000,000 -528,000,000 -1,244,000,000 -570,000,000 -347,000,000 -1,002,000,000 -1,064,000,000 -227,000,000 -159,000,000 -407,000,000 -404,000,000 -1,248,000,000 -519,000,000 -2,047,000,000 -154,000,000 -104,000,000 -316,000,000 -186,000,000 -588,000,000 -116,000,000 -163,000,000 -196,000,000 
      proceeds from government incentives
    		711,000,000 266,000,000 963,000,000 65,000,000 48,000,000 33,000,000 149,000,000 85,000,000 462,000,000 184,000,000 62,000,000 2,000,000 11,000,000 38,000,000 11,000,000 55,000,000 160,000,000 159,000,000 136,000,000 40,000,000 122,000,000 35,000,000 83,000,000 22,000,000 80,000,000 213,000,000 219,000,000 236,000,000         
      proceeds from maturities and sales of available-for-sale securities
    		449,000,000 375,000,000 446,000,000 428,000,000 361,000,000 707,000,000 352,000,000 374,000,000                             
      net cash from investing activities
    		-5,198,000,000 -2,589,000,000 -3,152,000,000 -3,148,000,000 -3,598,000,000 -2,002,000,000 -1,151,000,000 -1,558,000,000 -830,000,000 -1,180,000,000 -1,915,000,000 -2,266,000,000 -3,824,000,000 -2,585,000,000 -2,691,000,000 -2,485,000,000 -2,534,000,000 -2,081,000,000 -2,556,000,000 -3,418,000,000 -2,738,000,000 -1,952,000,000 -1,710,000,000 -1,189,000,000 -1,100,000,000 -2,066,000,000 -2,492,000,000 -4,427,000,000 -2,129,000,000 -2,244,000,000 -2,409,000,000 -1,434,000,000 -1,530,000,000 -472,000,000 -472,000,000 21,000,000 
      cash flows from financing activities
    		                                    
      repayments of debt
    		-1,015,000,000 -978,000,000 -2,542,000,000 -84,000,000 -81,000,000 -715,000,000 -1,048,000,000 -53,000,000 -55,000,000 -653,000,000 -33,000,000 -20,000,000 -24,000,000 -27,000,000 -32,000,000 -1,949,000,000 -176,000,000 -1,241,000,000 -19,000,000 -84,000,000 -80,000,000 -2,610,000,000 -261,000,000 -1,415,000,000 -964,000,000 -1,671,000,000 -128,000,000 -577,000,000 -3,427,000,000 -3,388,000,000 -635,000,000 -2,744,000,000 -709,000,000 -1,147,000,000 -1,250,000,000 -737,000,000 
      payments of dividends to shareholders
    		-130,000,000 -131,000,000 -130,000,000 -131,000,000 -129,000,000 -128,000,000 -127,000,000 -129,000,000 -126,000,000 -126,000,000 -126,000,000 -126,000,000 -126,000,000 -111,000,000 -112,000,000 -112,000,000                     
      repurchases of common stock - repurchase program
    		        0 0 0 -425,000,000 -784,000,000 -981,000,000 -408,000,000 -259,000,000                     
      payments on equipment purchase contracts
    		    -22,000,000 -45,000,000 -26,000,000 -56,000,000 -26,000,000 -36,000,000 -29,000,000 -47,000,000 -9,000,000 -27,000,000 -27,000,000 -78,000,000 -156,000,000 -16,000,000 -26,000,000 -97,000,000 -14,000,000 -20,000,000 -18,000,000 -11,000,000 -21,000,000 -17,000,000 -17,000,000 -20,000,000 -36,000,000 -17,000,000 -20,000,000 -133,000,000 -187,000,000 -89,000,000 -60,000,000 -143,000,000 
      proceeds from issuance of debt
    		0 1,748,000,000   0 0   0 1,495,000,000 1,872,000,000 3,349,000,000 0 0 0 2,000,000,000 0    0 3,750,000,000 0 1,250,000,000 1,750,000,000 0   40,000,000 319,000,000 500,000,000 150,000,000 1,150,000,000 0   
      net cash from financing activities
    		-1,064,000,000 540,000,000 96,000,000 -422,000,000 -474,000,000 -910,000,000 -106,000,000 -352,000,000 -112,000,000 661,000,000 1,802,000,000 2,632,000,000 -840,000,000 -1,161,000,000 -466,000,000 -513,000,000 -1,344,000,000 -228,000,000 5,000,000 -214,000,000 -182,000,000 1,072,000,000 -215,000,000 -992,000,000 892,000,000 -1,847,000,000 952,000,000 -2,435,000,000 -3,333,000,000 -3,023,000,000 -138,000,000 -1,282,000,000 286,000,000 -1,228,000,000 -271,000,000 -735,000,000 
      effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash
    		9,000,000 46,000,000 -20,000,000 -29,000,000 55,000,000 -7,000,000 -7,000,000 -1,000,000 -21,000,000 -22,000,000 15,000,000 -6,000,000 -35,000,000 -55,000,000 -10,000,000 -6,000,000 -3,000,000 1,000,000 16,000,000 27,000,000 19,000,000 6,000,000 0 -14,000,000 20,000,000 7,000,000 9,000,000 -10,000,000 -33,000,000 -8,000,000 10,000,000 -6,000,000     
      net increase in cash, cash equivalents, and restricted cash
    		-523,000,000 2,606,000,000 866,000,000 -355,000,000 -612,000,000 -437,000,000 -45,000,000 -510,000,000 -714,000,000 -517,000,000 245,000,000 1,303,000,000 -922,000,000 37,000,000 461,000,000 934,000,000 3,000,000 1,252,000,000 522,000,000 -1,638,000,000 -630,000,000    2,045,000,000 -1,195,000,000 1,904,000,000 -2,062,000,000 -340,000,000 -1,014,000,000 1,811,000,000 914,000,000     
      cash, cash equivalents, and restricted cash at beginning of period
    		0 0 0 7,052,000,000 0 0 0 8,656,000,000 0 0 0 8,339,000,000 0 0 0 7,829,000,000 0 0 0 7,690,000,000 0 0 0 7,279,000,000 0 0 0 6,587,000,000 0 0 0 5,216,000,000     
      cash, cash equivalents, and restricted cash at end of period
    		-523,000,000 2,606,000,000 866,000,000 6,697,000,000 -612,000,000 -437,000,000 -45,000,000 8,146,000,000 -714,000,000 -517,000,000 245,000,000 9,642,000,000 -922,000,000 37,000,000 461,000,000 8,763,000,000 3,000,000 1,252,000,000 522,000,000 6,052,000,000 -630,000,000 1,149,000,000 76,000,000 7,095,000,000 2,045,000,000 -1,195,000,000 1,904,000,000 4,525,000,000 -340,000,000 -1,014,000,000 1,811,000,000 6,130,000,000     
      supplemental disclosures
    		                                    
      income taxes paid
    		                                    
      interest paid, net of amounts capitalized
    		                                    
      non-cash equipment acquisitions on contracts payable
    		                                    
      other current assets
    		 -2,000,000    364,000,000                               
      proceeds from sale of lehi, utah fab
    		            0 -5,000,000 0 893,000,000                     
      noncash equipment acquisitions on contracts payable
    		                                    
      provision to write-down inventories to net realizable value
    		                                    
      restructure and asset impairments
    		            1,000,000    8,000,000                   -8,000,000 
      loss on debt repurchases and conversions
    		                              23,000,000 195,000,000     
      proceeds from maturities of available-for-sale securities
    		        396,000,000 405,000,000 407,000,000 358,000,000 357,000,000 333,000,000 318,000,000 313,000,000 226,000,000 278,000,000 530,000,000 216,000,000 178,000,000 113,000,000 360,000,000 163,000,000 915,000,000 235,000,000 331,000,000 60,000,000 101,000,000 81,000,000 53,000,000 85,000,000     
      proceeds from sales of available-for-sale securities
    		        3,000,000 14,000,000 4,000,000 4,000,000 36,000,000 86,000,000 48,000,000 124,000,000 383,000,000 295,000,000 133,000,000 45,000,000 301,000,000 98,000,000 71,000,000 988,000,000 233,000,000 1,111,000,000 83,000,000 77,000,000 35,000,000 7,000,000 8,000,000 554,000,000     
      (gain) loss on debt repurchases
    		                                    
      (gain) loss on debt repurchases and conversions
    		            0 0 0 83,000,000                     
      repurchases of common stock - withholdings on employee equity awards
    		            -9,000,000 -4,000,000 -10,000,000 -102,000,000                     
      acquisition of noncontrolling interest in imft
    		                    0 0 0 -744,000,000             
      adjustments to reconcile net income to net cash from operating activities
    		                                    
      change in operating assets and liabilities
    		                                    
      deferred income taxes
    		               54,000,000 44,000,000 -83,000,000 13,000,000 -24,000,000 53,000,000 -12,000,000 19,000,000 19,000,000 -45,000,000    -49,000,000 46,000,000   -116,000,000 57,000,000 68,000,000 59,000,000 
      amortization of debt discount and other costs
    		                8,000,000 7,000,000 8,000,000 7,000,000 6,000,000 4,000,000 6,000,000 10,000,000 10,000,000 10,000,000 11,000,000 18,000,000 23,000,000 23,000,000 26,000,000 29,000,000 37,000,000 36,000,000 44,000,000 50,000,000 
      (gains) losses on debt prepayments, repurchases, and conversions
    		                                    
      payments to acquire treasury stock
    		                    -48,000,000 -44,000,000 -70,000,000 -89,000,000 -2,000,000 -159,000,000 -732,000,000 -1,836,000,000         
      noncash equipment acquisitions on contracts payable and finance leases
    		                                    
      (gain) loss on debt prepayments, repurchases, and conversions
    		                           -14,000,000         
      proceeds from issuance of stock
    		                        67,000,000 20,000,000 77,000,000 15,000,000 19,000,000 82,000,000 82,000,000 1,472,000,000     
      (gains) losses on debt prepayments and conversions
    		                                    
      net decrease in cash, cash equivalents, and restricted cash
    		                      76,000,000 -184,000,000             
      gain on debt prepayments, repurchases, and conversions
    		                       -42,000,000             
      loss on debt prepayments, repurchases, and conversions
    		                        10,000,000 317,000,000   -1,000,000        
      gain on remeasurement of previously-held equity interest in inotera
    		                                    
      payments attributed to intercompany balances with inotera
    		                                    
      acquisition of inotera
    		                                    
      noncash investing and financing activity
    		                                    
      equipment acquisitions on contracts payable and capital leases
    		                                293,000,000 86,000,000 128,000,000 80,000,000 
      deferred tax assets
    		                          128,000,000 192,000,000         
      payments to settle hedging activities
    		                            -101,000,000 -56,000,000 -11,000,000 -17,000,000 -1,000,000    
      proceeds from settlement of hedging activities
    		                            12,000,000 40,000,000 83,000,000 28,000,000     
      proceeds from equipment sale-leaseback transactions
    		                                0 0 0 14,000,000 
      other noncurrent liabilities
    		                                    
      equity in net (income) loss of equity method investees
    		                                -119,000,000 -135,000,000 -134,000,000 -86,000,000 
      deferred income
    		                                    
      proceeds from sales and maturities of available-for-sale securities
    		                                115,000,000 122,000,000 158,000,000 162,000,000 
      proceeds from issuance of stock under equity plans
    		                                    
      cash paid to acquire treasury stock
    		                                    
      loss on restructure of debt
    		                                13,000,000 16,000,000   
      (gain) income from currency hedges
    		                                    
      equity in net income of equity method investees
    		                                    
      gain from inotera issuance of shares
    		                                    
      gain from disposition of interest in aptina
    		                                    
      increase in restricted cash
    		                                    
      cash received from disposition of interest in aptina
    		                                    
      contributions from noncontrolling interests
    		                                    
      acquisition of noncontrolling interests
    		                                    
      effect of changes in currency exchange rates on cash and equivalents
    		                                    
      net increase in cash and equivalents
    		                                88,000,000 -243,000,000 651,000,000 774,000,000 
      cash and equivalents at beginning of period
    		                                0 0 0 2,880,000,000 
      cash and equivalents at end of period
    		                                88,000,000 -243,000,000 651,000,000 3,654,000,000 
      noncash investing and financing activities
    		                                    
      exchange of convertible notes
    		                                0 0 0 756,000,000 
      acquisition of noncontrolling interest
    		                                0 0   
      •
    		                                    
      noncash restructure and asset impairment
    		                                    
      (gain) on mmj acquisition
    		                                    
      expenditures for property, plant and equipment
    		                                -1,140,000,000 -487,000,000 -505,000,000 -526,000,000 
      income taxes refunded (paid)
    		                                    
      noncash investing and financing activities:
    		                                    
      assets acquired and liabilities assumed:
    		                                    
      cash and equivalents
    		                                    
      restricted cash
    		                                    
      property, plant and equipment
    		                                    
      equity method investment
    		                                    
      intangible assets
    		                                    
      other noncurrent assets
    		                                    
      current portion of long-term debt
    		                                    
      long-term debt
    		                                    
      total net assets acquired
    		                                    
      noncontrolling interest in mmj
    		                                    
      consideration
    		                                    
      preliminary gain on acquisition recognized in 2013
    		                                    
      adjustment for preliminary pre-petition liabilities
    		                                    
      final gain on acquisition
    		                                    
      (gains) losses from currency hedges
    		                                8,000,000 -2,000,000 7,000,000 14,000,000 
      noncash restructure and asset impairments
    		                                0    
      additions to equity method investments
    		                                    
      decrease in restricted cash
    		                                -23,000,000 3,000,000 0 556,000,000 
      cash paid to purchase stock under equity plans
    		                                    
      acquisitions of noncontrolling interests
    		                                    
      distributions to noncontrolling interests
    		                                    
      conversion of notes to stock, net of unamortized issuance cost
    		                                    
      equipment purchase contracts
    		                                    
      noncontrolling interests in mmj
    		                                    
      adjustment for primarily pre-petition liabilities
    		                                    
      adjustment to gain on mmj acquisition
    		                                    
      customer prepayments
    		                                 -82,000,000 -59,000,000 212,000,000 
      cash paid to purchase common stock under equity plans
    		                                    
      cash paid for capped call transactions
    		                                    
      proceeds from issuance of common stock under equity plans
    		                                 23,000,000 80,000,000 144,000,000 
      cash received from capped call transactions
    		                                    
      effect of changes in currency exchange rates on cash and cash equivalents
    		                                 2,000,000   
      adjustment to gain on acquisition of elpida
    		                                    
      cash paid to purchase common stock
    		                                  -31,000,000 -42,000,000 
      cash received from noncontrolling interests
    		                                  0 49,000,000 
      noncash loss on restructure of debt
    		                                   86,000,000 
      cash received for capped call transactions
    		                                    
      effect on changes in foreign currency exchange rates on cash and cash equivalents
    		                                   -19,000,000 
      loss on extinguishment of debt
    		                                    
      gain from acquisition of elpida
    		                                    
      change in operating assets and liabilities, net of amounts from elpida acquisition:
    		                                    
      cash acquired from acquisition of elpida, net of cash paid
    		                                    
      proceeds from sales of property, plant and equipment
    		                                    
      return of equity method investment
    		                                    
      noncontrolling interests in elpida:
    		                                    
      gain on acquisition
    		                                    
      gain from disposition of japan fab
    		                                    
      gain from acquisition of numonyx
    		                                    
      proceeds from sale of interest in hynix jv
    		                                    
      cash acquired from acquisition of numonyx
    		                                    
      cash (paid) received for capped call transactions
    		                                    
      stock and restricted stock units issued in acquisition of numonyx
    		                                    
      acquisition of interest in transform
    		                                    
      for the year ended
    		                                    
      net sales
    		                                    
      net income attributable to micron
    		                                    
      earnings per share:
    		                                    
      basic
    		                                    
      diluted
    		                                    
      equity in net incomees of equity method investees, net of tax
    		                                    
      provision to write-down inventories to estimated market values
    		                                    
      restructure charges
    		                                    
      (gain) income from disposition of property, plant and equipment
    		                                    
      gain from inotera and hynix jv stock issuances
    		                                    
      acquisition of noncontrolling interests in tech
    		                                    
      decrease (increase) in restricted cash
    		                                    
      cash paid to purchase capped calls
    		                                    
      proceeds from debt
    		                                    
      proceeds from issuance of common stock
    		                                    
      consideration:
    		                                    
      fair value of common stock issued
    		                                    
      fair value of restricted stock units issued
    		                                    
      recognized amounts of identifiable assets acquired and liabilities assumed:
    		                                    
      depreciation and amortization
    		                                    
      increase in receivables
    		                                    
      increase in inventories
    		                                    
      increase in accounts payable and accrued expenses
    		                                    
      increase in customer prepayments
    		                                    
      consolidation of tech
    		                                    
      cash acquired from acquisition of lexar
    		                                    
      capital contribution from noncontrolling interest in imft
    		                                    
      proceeds from settlement of call spread options
    		                                    
      proceeds from sale of noncontrolling interest in mp mask
    		                                    
      proceeds from issuance of stock rights
    		                                    
      redemption of common stock
    		                                    
      cash and equivalents at beginning of year
    		                                    
      cash and equivalents at end of year
    		                                    
      stock and stock options issued in acquisition of lexar
    		                                    
      investment securities
    		                                    
      available-for-sale securities:
    		                                    
      commercial paper
    		                                    
      u.s. government and agencies
    		                                    
      certificates of deposit
    		                                    
      corporate notes and bonds
    		                                    
      repurchase agreements
    		                                    
      less cash equivalents
    		                                    
      less noncurrent investments
    		                                    
      short-term investments
    		                                    
      noncash restructure and other charges
    		                                    
      provision to write down inventories to estimated market values
    		                                    
      gain from write-down or disposition of equipment
    		                                    
      gain from write-down or disposition of investments
    		                                    
      debt issuance costs
    		                                    
      purchase of call spread options
    		                                    
      net income, as reported
    		                                    
      redeemable common stock accretion
    		                                    
      redeemable common stock fair value adjustment
    		                                    
      net income available to common shareholders
    		                                    
      stock-based employee compensation expense included in reported net income, net of tax
    		                                    
      less total stock-based employee compensation expense determined under a fair value-based method for all awards, net of tax
    		                                    
      pro forma net income available to common shareholders
    		                                    
      basic, as reported
    		                                    
      basic, pro forma
    		                                    
      diluted, as reported
    		                                    
      diluted, pro forma
    		                                    
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.